Showing results (441-450 of 501) with videos related to
Sort By:
Pageof 51
Journal of Diabetes Science and Technology|May 20, 2015
Predictors of Hypoglycemia in the ASPIRE In-Home Study and Effects of Automatic Suspension of Insulin DeliveryRam Weiss, Satish K Garg, Richard M Bergenstal, et al.Diabetes Technology & Therapeutics|October 22, 2008
Self-Monitoring of Blood Glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and researchIrl B Hirsch, Bruce W Bode, Belinda P Childs, et al.Nature|September 4, 1997
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1F X Gomis-Rüth, K Maskos, M Betz, et al.Diabetes Technology & Therapeutics|July 13, 2017
Accuracy of a Fourth-Generation Subcutaneous Continuous Glucose SensorMark P Christiansen, Satish K Garg, Ronald Brazg, et al.Science Advances|October 27, 2023
High-throughput synthesis provides data for predicting molecular properties and reaction successJulian Götz, Moritz K Jackl, Chalupat Jindakun, et al.The New England Journal of Medicine|June 25, 2013
Threshold-based insulin-pump interruption for reduction of hypoglycemiaRichard M Bergenstal, David C Klonoff, Satish K Garg, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 29, 2013
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trialB W Bode, J B Buse, M Fisher, et al.Diabetes Care|June 8, 2015
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 DiabetesArthur T Sands, Brian P Zambrowicz, Julio Rosenstock, et al.Diabetes Technology & Therapeutics|July 11, 2018
Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D ExchangeSarit Polsky, Mengdi Wu, Bruce W Bode, et al.Science (New York, N.Y.)|May 24, 2021
Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genomePramod R Bhatt, Alain Scaiola, Gary Loughran, et al.Pageof 51